Related Experiment Video

Updated: Jun 19, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Anticoagulant therapy in acute coronary syndromes

Eric R Bates1

  • 1B1 238 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0022, USA. ebates@umich.edu

Future Cardiology
|October 7, 2009
PubMed

Insights

New anticoagulants like enoxaparin, bivalirudin, and fondaparinux offer improved efficacy or safety over unfractionated heparin for acute coronary syndromes (ACS). These agents present advantages in administration, monitoring, and treatment duration, but require careful management to mitigate bleeding risks.

Area of Science:

  • Cardiology
  • Pharmacology
  • Vascular Biology

Background:

  • Acute coronary syndromes (ACS) are typically caused by thrombus formation on ruptured atherosclerotic plaques.
  • Current standard treatment involves unfractionated heparin and aspirin, but unfractionated heparin has limitations in efficacy and safety.

Purpose of the Study:

  • To review newer anticoagulant options for ACS, including low-molecular-weight heparins, direct thrombin inhibitors, and Factor Xa inhibitors.
  • To compare the efficacy and safety profiles of these novel agents against unfractionated heparin.

Main Methods:

  • Literature review and analysis of clinical trial data comparing different anticoagulant therapies in ACS patients.
  • Evaluation of pharmacological properties, administration requirements, and clinical outcomes associated with each agent.

Main Results:

  • Enoxaparin and fondaparinux demonstrate easier administration, no need for monitoring, and allow longer treatment durations compared to unfractionated heparin.
  • Bivalirudin shows specific benefits for patients undergoing percutaneous revascularization.
  • All newer agents offer potential improvements in efficacy or safety over unfractionated heparin.

Conclusions:

  • Novel anticoagulants provide valuable alternatives to unfractionated heparin in managing ACS.
  • Careful dosing and vascular access site management are crucial to minimize bleeding complications and associated mortality risks.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...